Micronucleus frequency in human umbilical cord lymphocytes

Area of Science:

• Environmental Health
• Genetics
• Toxicology

Background:

• The human fetus is vulnerable to environmental agents and drugs crossing the placenta, potentially causing DNA damage.
• Micronucleus (MN) determination is a sensitive method for assessing DNA damage.
• Umbilical cord blood offers a risk-free source for newborn biological samples.

Purpose of the Study:

• To evaluate the frequency of micronuclei (MN) in newborns' cord blood cells.
• To assess the utility of MN testing in identifying transplacental mutagens.
• To compare MN frequencies in newborns from urban, agricultural, and high-risk pregnancy groups.

Main Methods:

• Micronucleus (MN) frequency was measured in cord blood cells from newborns in urban, agricultural, and high-risk pregnancy groups.
• MN levels were also assessed in mothers from urban and agricultural areas.
• Acetylcholinesterase (AChE) concentration was measured in select groups.

Main Results:

• A significant correlation (r=0.61, p<0.01) was observed between MN frequency in mothers and their newborns.
• Newborns from high-risk pregnancies exhibited a significantly higher MN frequency (4+/-2 per 1000 cells, p<0.01) compared to controls.
• No significant differences in AChE levels were found between groups.

Conclusions:

• Micronucleus (MN) evaluation in umbilical cord blood is a valuable tool for identifying fetal exposure to mutagens.
• Prenatal exposure to environmental agents can lead to detectable DNA damage in newborns.
• This method aids in understanding the impact of environmental factors on fetal development and health.